Webinar on the use of platform approaches in the non-clinical and clinical domains | European Medicines Agency (EMA) www.ema.europa.eu/en/events/we...

It has been a great symposium! Thanks to all participants, looking forward to the next edition!

2nd VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology DAY 1 YouTube video by Vall d'Hebron Institute of Oncology - VHIO

✨ Good morning from Casa de la Convalescència, Barcelona!

🛜 We’re live at the 2nd VHIO - BBVA Foundation Symposium on Cell-Based Therapies in Cancer — two inspiring days ahead filled with innovation, science, and great minds!

🔗 Watch live: youtube.com/live/egVp3sW...

#VHIOBBVASymposium #SOMMVhio

It has been a great symposium! Thanks to all participants, looking forward to the next edition!

We joined forces across Europe to map, connect & accelerate the development of ATMPs — gene, cell and tissue-based therapies that could transform patient care.

We make ATMP innovation faster, safer and more accessible for everyone.

👉 join4atmp.eu

#JOIN4ATMP #ATMP #HorizonEurope #HealthInnovation

Very happy to have participated in the Summer School in Translational
Cancer Research 2025, from 5 to 10 October, 2025, discussing about:

"Reviving TIL-ACT: Rediscovering an effective melanoma treatment after more than two decades"

#CCESumSchool25; @vhio.bsky.social
lnkd.in/d-7tuR88

Thanks for the invitation to @caixaresearch.bsky.social ! It was a great opportunity to discuss with great researchers!

Un grito por el Museo Cajal Científicos y familiares de Santiago Ramón y Cajal piden la creación urgente de un Museo Nacional dedicado al padre de la neurociencia, como prometieron el presidente Pedro Sánchez y la ministra Diana...

Es hora de pasar a la acción, el tantas veces anunciado Museo Cajal debe ser una realidad ya. El más grande de nuestros sabios lo merece desde hace mucho tiempo. Subscribo esta carta preparada por muchos colegas y amigos que publica hoy @elpais.com ⬇️
elpais.com/ciencia/2025...

La unidad de Cáncer Pediátrico del CNIO trata con éxito en el hospital La Paz una enfermedad rara autoinmune con una terapia CAR-T La Unidad Mixta de Investigación Clínica de Oncohematología Pediátrica IdiPAZ-CNIO, dirigida por el oncólogo Antonio Pérez Martínez, investiga «para solucionar los problemas que aparecen en la clínica...

La unidad de cáncer pediátrico del CNIO ha tratado a una niña con la enfermedad rara dermatomiositis anti-MDA5 con una CAR-T
Hospital público La Paz

"Investigar en el CNIO nos ayudará a aplicar lo aprendido a futuros casos" @andresparismu.bsky.social
@mcti.bsky.social
www.cnio.es/noticias/la-...

El cero y el infinito La colaboración es una ventaja evolutiva. A la larga, nadie se salva sin contar con apoyos

El cero y el infinito
elpais.com/opinion/2025...

Cooperación como fuente de éxito, la clave

No estamos calentando. Fuente: svs.gsfc.nasa.gov/5190/

Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis - PubMed TIL-ACT, a new approved and promising therapy for melanoma patients, presents a distinctive toxicity profile that is currently manageable with supportive care methods, with reported toxicities mainly ...

Have a look into our last publication, a great collaborative effort reviewing TIL-ACT safety, aiming to facilitate access for patients.
pubmed.ncbi.nlm.nih.gov/40210086/

👩🏻‍💻 👩🏻‍⚕️ 🧑🏻‍🔬 At VHIO, we transform knowledge into health, quality of life, and new opportunities. Working tirelessly against cancer, we believe in the power of what we do

🌐 vhio.net

With: Vall d'Hebron Barcelona Hospital Campus; SOMM Alliance and ICERCA

#oncology #cancer

'Si hacemos bien las cosas, se pueden evitar el 30% de los tumores'

💬 “Si hacemos bien las cosas, se pueden evitar el 30% de los tumores”

Josep Tabernero, director del #VHIO, destaca la importancia de la prevención, la investigación y los recursos para combatir el cáncer 👇

Announcing the new bioRxiv dashboard widget - it's now easier to when articles have comments, peer reviews, community discussion, media coverage, videos, and automated analyses 1/2 connect.biorxiv.org/news/2025/01...

Our lab wishes you all a Merry Christmas!

We finish the scientific year at the @irbbarcelona.org Christmas party with the best costume ever!! 🤣🤣🤣

⚠️ Gene editing may be considered a misleading term as nowadays we are far beyond "just changing the DNA"!

Here is what we can do!

Want more WeDoCRISPR content?
Follow us on LinkedIN and Check out our YouTube channel: lnkd.in/dPCqParT

#crispr #crisprcas9 #geneediting #geneandcelltherapy